PT  - JOURNAL ARTICLE
AU  - Faust, Jeremy S.
AU  - Lin, Zhenqiu
AU  - Krumholz, Harlan M.
TI  - Heart Disease Deaths during the Covid-19 Pandemic
AID  - 10.1101/2020.06.04.20122317
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.04.20122317
4099  - http://medrxiv.org/content/early/2020/06/08/2020.06.04.20122317.short
4100  - http://medrxiv.org/content/early/2020/06/08/2020.06.04.20122317.full
AB  - The SARS-CoV-2 pandemic is associated with a reduction in hospitalization for an acute cardiovascular conditions. In a major health system in Massachusetts, there was a 43% reduction in these types of hospitalizations in March 2020 compared with March 2019.4 Whether mortality rates from heart disease have changed over this period is unknown.We assembled information from the National Center for Health Statistics (Centers for Disease Control and Prevention) for 118,356,533 person-weeks from Week 1 (ending January 4) through Week 17 (ending April 25) of 2020 for the state of Massachusetts. We found that heart disease deaths are unchanged during the Covid-19 pandemic period as compared to the corresponding period of 2019. This is despite reports that admissions for acute myocardial infarction have fallen during this time.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project has no specific funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data is from the CDC. No IRB necessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is available to the public. https://www.cdc.gov/nchs/data/vsrr/report001.pdf https://www.cdc.gov/nchs/data/vsrr/report001.pdf